心臓由来幹細胞研究から想定される心臓拍動持続促進因子
川口奈奈子， 松岡瑠美子， 中西敏雄 - 日本小児循環器学会雑誌, 2014 - jstage.jst.go.jp
抄録 心筋梗塞後に低下した心機能回復のための治療に, 胚性幹細胞, induced pluripotent stem
cell (iPS 細胞), 体性幹細胞などを用いた幹細胞医療が注目されている. 胚性幹細胞および iPS …
cell (iPS 細胞), 体性幹細胞などを用いた幹細胞医療が注目されている. 胚性幹細胞および iPS …
Promoting differentiation and survival of human c-kit+ cardiac progenitor cells ex vivo.
T Al-Maqtari - 2015 - ir.library.louisville.edu
Abstract c-kit+ cardiac progenitor cells (CPCs) have recently gained much attention due to
the therapeutic effects they exert on cardiac function following their administration into the …
the therapeutic effects they exert on cardiac function following their administration into the …
第22 回犬山不整脈カンファランスメインテーマ心筋再生医療と特発性心室細動テーマI 基礎「再生医療の新しい細胞ソースと技術」 心臓組織内幹細胞を用いた心不全への心筋 …
王英正 - 心電図, 2008 - jstage.jst.go.jp
急性または慢性心不全に対する細胞移植療法の臨床的研究開発はここ数年間で大いなる進歩を
遂げている. 多 くの臨床治験が世界規模かつ多施設共同研究のレベルで行われ, 革 …
遂げている. 多 くの臨床治験が世界規模かつ多施設共同研究のレベルで行われ, 革 …
Fibroblast growth factors and vascular endothelial growth factor promote cardiac reprogramming under defined conditions (要約)
山川裕之 - 2016 - koara.lib.keio.ac.jp
近年, iPS 細胞を介さずに様々な細胞が誘導され, 新たな再生医療の細胞源として注目されている.
その中で iPS 細胞を介されず心筋様細胞 (induced cardiomyocytes; 以降 iCM 細胞と略す) が …
その中で iPS 細胞を介されず心筋様細胞 (induced cardiomyocytes; 以降 iCM 細胞と略す) が …
End-Stage Human Failing Heart Increases Functional Cardiac Progenitor Cells
Background: Human cases of end-stage heart failure provide the rare opportunity to test
whether the cells within these hearts exhibit different phenotypic characteristics than those in …
whether the cells within these hearts exhibit different phenotypic characteristics than those in …
ヒトiPS 細胞からの心筋細胞分化誘導技術の開発-機能発現の確認と疾患患者iPS 細胞からの創薬支援技術への展開の可能性
福田恵一 - 日本トキシコロジー学会学術年会第37 回日本 …, 2010 - jstage.jst.go.jp
抄録 [緒言] ヒト iPS 細胞を用いて心筋細胞の分化誘導, 細胞増殖, 純化精製を行い,
創薬利用・再生医療に結びつけるには種々の技術革新 を行う必要がある.[目的] _ 丸 1_iPS …
創薬利用・再生医療に結びつけるには種々の技術革新 を行う必要がある.[目的] _ 丸 1_iPS …
Cardiac myocyte progenitors from adult hearts for myocardial regenerative therapy
CF Yang, KY Chou, ZC Weng, SC Hung… - Journal of the …, 2008 - journals.lww.com
Background: The heart is a highly vascular organ and prolonged interruption of myocardial
blood flow initiates events that culminate in cardiac myocyte death. Proposed experimental …
blood flow initiates events that culminate in cardiac myocyte death. Proposed experimental …
End-Stage Human Failing Hearts Increase Cardiac Progenitor Cells by Switching to a Developmental Program
Background: Human cases of end-stage heart failure provide the rare opportunity to test
whether the cells within these hearts exhibit different phenotypic characteristics than those in …
whether the cells within these hearts exhibit different phenotypic characteristics than those in …
Directed Differentiation of c-kit+ Human Cardiac Stem Cells in vitro
KU Hong, TM Al-Maqtari, A Moktar, BN Vajravelu… - 2013 - Am Heart Assoc
Although transplantation of c-kit+ cardiac stem cells (CSCs) significantly alleviates post-
myocardial infarction (MI) left ventricular dysfunction, the exogenous CSCs in the recipient …
myocardial infarction (MI) left ventricular dysfunction, the exogenous CSCs in the recipient …
Cardiac Regenerative Therapy: from bone marrow stem cells to cardiac progenitors
R KONINCKX - 2010 - documentserver.uhasselt.be
After a MI the heart function is severely diminished due to an irreversible loss of CMs. The
heart is no longer considered a static organ but contains some intrinsic regenerative …
heart is no longer considered a static organ but contains some intrinsic regenerative …